Impact of FDA Decisions on Extended-Release and Long-Acting Opioids for

Impact of FDA Decisions On Extended-Release and Long-Acting Opioids for
AAPM further supported the Agency's decision to deny portions of a citizen petition seeking dosage and treatment duration limits that would have applied to every patient regardless of individual circumstance. The Academy had previously argued that the …
Read more on Science Daily (press release)